LYCOS RETRIEVER 
Rheumatoid Arthritis: Patients
built 641 days ago
Biologic response modifiers are new drugs used for the treatment of rheumatoid arthritis. They can help reduce inflammation and structural damage to the joints by blocking the action of cytokines, proteins of the body's immune system that trigger inflammation during normal immune responses. Three of these drugs, etanercept (Enbrel*), infliximab (Remicade), and adalimumab (Humira), reduce inflammation by blocking the reaction of TNF-α molecules. Another drug, called anakinra (Kineret), works by blocking a protein called interleukin 1 (IL-1) that is seen in excess in patients with rheumatoid arthritis.
Source:
Rheumatoid neutrophilic dermatitis (RND) is an unusual cutaneous reaction in patients with rheumatoid arthritis (RA). RND is characterized by symmetric, erythematous papules, plaques, nodules, and urticarial lesions often located over the joints, extensor surfaces of the extremities, or the trunk.
Source:
Researchers at Cincinnati Children's have issued the first study showing that a protein normally involved in blood clotting (fibrin)... plays an important role in the inflammatory response and development of rheumatoid arthritis. Inflammatory joint disease appears to be driven by the engagement of inflammatory cells with fibrin matrices through a specific integrin receptor, aMB2. Writing in the November issue of The Journal of Clinical Investigation, researchers suggest that therapies designed to interrupt the localized interaction of inflammatory cells and fibrin may help arthritis patients.
Source:
Until now, there is no known cure for rheumatoid arthritis. Reducing joint inflammation and pain, maximizing joint function, and preventing joint destruction is the current goal in treating rheumatoid arthritis. Early medical intervention has been found to improve outcomes in treatment. Optimal treatment includes combination of medications, joint strengthening exercises, joint protection, and patient education. Treatment is customized according to many factors such as disease activity, types of joints involved, general health, age, and occupation. But treatment is most successful when there is close cooperation between the doctor and the patient.
Source:
When RA is being clinically suspected, immunological studies are required, such as rheumatoid factor (RF, a specific antibody).[4] A negative RF does not rule out RA; rather, the arthritis is called seronegative. During the first year of illness, rheumatoid factor is frequently negative. 80% of patients eventually convert to seropositive status. RF is ... seen in other illnesses, like Sjögren's syndrome, and in approximately 10% of the healthy population, therefore the test is not very specific.
Source:
Plaquenil or hydroxychloroquine is an anti-malarial agent with anti-inflammatory properties in rheumatoid arthritis. Like gold it is used in those patients who fail to respond to a conservative regimen including rest, salicylates and/or other nonsteroidal anti- inflammatory drugs. These are given orally. Ophthalmologic monitoring is necessary to check for visual loss at an early reversible stage. Patients should be seen by their eye doctors a minimum of once a year. This therapy should be discontinued if any eye problems are related to the medication.
Source:
MORE ABOUT
Patients